Amendment Statement of Principles
No. 73 of 2014
for the purposes of the
Veterans’ Entitlements Act 1986
Military Rehabilitation and Compensation Act 2004
1. This Instrument may be cited as Amendment Statement of Principles concerning myeloma No. 73 of 2014.
2. In accordance with the Specialist Medical Review Council Declaration No. 23 of 12 May 2014 under subsection 196W(4) of the Veterans’ Entitlements Act 1986 (the VEA), the Repatriation Medical Authority amends, pursuant to subsection 196B(10) of the VEA, Statement of Principles concerning myeloma Instrument No. 70 of 2012, by:
A. Inserting additional factor "(ca)" immediately following factor "(c)" in clause 6 as follows:
"(ca) having exposure to 2,3,7,8 tetrachlorodibenzo-para-dioxin (TCDD) sufficient to produce an expected initial serum TCDD level of at least 1 500 parts per trillion before the clinical onset of myeloma; or".
3. The amendment made by this instrument applies to all matters to which Instrument No. 70 of 2012, section 120B of the Veterans’ Entitlements Act 1986 and section 339 of the Military Rehabilitation and Compensation Act 2004 apply.
4. The amendment made by this instrument takes effect from 13 May 2014.
Dated this twentieth day of June 2014
The Common Seal of the )
Repatriation Medical Authority )
was affixed at the direction of: )
PROFESSOR NICHOLAS SAUNDERS AO